Should We Start Prescribing Omega-3 Polyunsaturated Fatty Acids in Chronic Heart Failure?
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Chronic heart failure (HF) represents a significant health care burden. Over the past few decades, there have been considerable data supporting the benefits of omega-3 polyunsaturated fatty acids (PUFAs) on overall cardiovascular health. Reasons for the potential benefits of omega-3 PUFAs are multifactorial and not completely understood. It is likely that the culmination of multiple effects collectively help to prevent the development and slow the progression of chronic HF. A number of key epidemiologic and randomized trials have provided the basis of evidence in support of omega-3 PUFA supplementation in HF. This article reviews the benefits of omega-3 PUFAs and discusses the implications of recent trials. While the benefits seen in patients with chronic HF are modest at best, we believe the balance of evidence still favors the continuation of omega-3 PUFA supplementation in patients with chronic HF.
- Heart Disease and Stroke Statistics--2011 Update: A Report From the American Heart Association. Circulation 2011, 123:e18-e209
- • Lee J, Jarreau T, Prasad A, et al.: Nutritional assessment in heart failure patients. Congestive Heart Failure 2011, 17:199–203. This is a well-written review paper on the benefits of nutritional supplementation, including omega-3 fatty acids, in the heart failure patient. CrossRef
- Wang C, Harris WS, Chung M, et al. n-3 Fatty acid from fish or fish-oil supplements, but not a-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr. 2006;84(1):5–17.
- Duda M, O’Shea K, Stanley W. Omega-3 polyunsaturated fatty acid supplementation for the treatment of heart failure: mechanisms and clinical potential. Cardiovasc Res. 2009;84:33–41. CrossRef
- Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 acids and cardiovascular disease. Circulation. 2002;106(21):2747–57. CrossRef
- Weber P, Raederstorff D. Triglyceride-lowering effect of omega-3 LC-polyunsaturated fatty acids –a review. Nutr Metab Cardiovasc Dis. 2000;10:28–37.
- Lavie CJ, O’Keefe JH, Milani RV, et al. New data on the clinical impact of exercise training, fish oils, and statins in heart failure. Phys Sports Med. 2009;37(2):22–8. CrossRef
- •• Lavie CJ, Milani RV, Mehra MR, Ventura HO: Omega-3 polyunsaturated fatty acids and cardiovascular diseases-a fish tale with growing credibility. J Am Coll Cardiol 2009, 54:585–594. This is an excellent paper that summarizes the major clinical trials and provides expert insight on the benefits of omega-3 PUFAs. CrossRef
- London B, Albert C, Anderson ME, et al. Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office Of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmogenesis Workshop. Circulation. 2007;116:e320–35. CrossRef
- Jacobson TA. Role of n-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease. Am J Clin Nutr. 2008;87:1981S–90S.
- Harris WS. Omega-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997;65:1645S–54S.
- Robinson JG. Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids. Am J Cardiol. 2006;98:39i–49i. CrossRef
- Din JN, Harding SA, Valerio CJ, et al.: Dietary intervention with oil rich fish reduces platelet-monocyte aggregation in man. Atherosclerosis. 2007, E-pub ahead of print.
- Leaf A, Weber PC. Cardiovascular effects of omega-3 fatty acids. N Engl J Med. 1988;318:549–57. CrossRef
- Lortet S, Verger P. Alteration of cardiovascular function in trained rats fed with fish oil. Int J Sports Med. 1995;16:519–21. CrossRef
- Pepe S, McLennan PL. Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function. Circulation. 2002;105:2303–8. CrossRef
- Dallongeville J, Yarnell J, Ducimetiere P, et al. Fish consumption is associated with lower heart rates. Circulation. 2003;108:820–5. CrossRef
- Mozaffarian D, Geelen A, Brouwer I, et al. Effect of fish oil on heart rate-a meta-analysis of randomised controlled trials. Circulation. 2005;112:1945–52. CrossRef
- Peoples GE, McLennan PL, Howe PRC, Groeller H. Fish oil reduces heart rate and oxygen consumption during exercise. J Cardiovasc Pharm. 2008;52(6):540–7. CrossRef
- Lee JH, O’Keefe JH, Lavie CJ, et al. Omega-3 fatty acids for cardioprotection. Mayo Clin Proc. 2008;83(3):324–32. CrossRef
- Mozaffarian D, Bryson CL, Lemaitre RN, et al. Fish intake and risk of incident heart failure. J Am Coll Cardiol. 2005;45:2015–21. CrossRef
- Yamagishi K, Nettleton JA, Folsom AR. Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk In Communities (ARIC) study. Am Heart J. 2008;156:965–74. CrossRef
- Yamagishi K, Iso H, Date C, et al. Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women. J Am Coll Cardiol. 2008;52:988–96. CrossRef
- GISSI-Prevenzione Investigators, Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999, 354 (9177):447 – 455.
- Tavazzi L, Tognoni G, Franzosi MG, et al. Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure. Eur J Heart Fail. 2004;6:635–41.
- Pepe S, McLennan P. Dietary fish oil confers direct antiarrhythmic properties on the myocardium of rats. J Nutr. 1996;126:34–42.
- McLennan P, Abeywardena MY, Charnock JS. Dietary fish oil prevents ventricular fibrillation following coronary artery occlusion and reperfusion. Am Heart J. 1988;116:709–17. CrossRef
- •• GISSI-HF Investigators: Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372 (9645):1223–1230. This is a major multicenter randomized clinical trial in heart failure patients. The results showed modest improvements in clinical outcomes and it is the first major trial to highlight the safety and tolerability to omega-3 PUFAs in conjunction with standard heart failure therapy.
- Witte KKA, Clark AL. Marine Polyunsaturated Fatty Acids in Heart Failure Are the theoretical benefits matched by clinical data? Pol Arch Med Wewn. 2009;119(3):162–8.
- Raitt MH, Conner WE, Morris C, et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators. JAMA. 2005;293:2884–91. CrossRef
- Brouwer IA, Zock PL, Camm AJ, et al. Effects of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators. JAMA. 2006;295:2613–9. CrossRef
- Leaf A, Albert CM, Josephson M, et al. Prevention of fatal arrhythmias in high-risk subjects by fish oil omega-3 fatty acid intake. Circulation. 2005;112:2762–8. CrossRef
- Schwengel RH, Gottlieb SS, Fisher ML. Protein-energy malnutrition in patients with ischaemic and non-ischaemic dilated cardiomyopathy and congestive heart failure. Am J Cardiol. 1994;73:908–10. CrossRef
- Barber MD, Ross JA, Voss AC, et al. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer. 1999;81:80–6. CrossRef
- Mehra MR, Lavie CJ, Ventura HO, Milani RV. Fish oils produce anti-inflammatory effects and improved body weight in severe heart failure. J Heart Lung Transplant. 2006;25(7):834–8. CrossRef
- Freeman LM, Rush JE, Kehayias JJ, et al. Nutritional alterations and the effect of fish oil supplementation in dogs with heart failure. J Vet Intern Med. 1998;12:440–8. CrossRef
- Lee JH, O’Keefe Jr JH. Lavie CJ, Harris WS: Omega-3 fatty acids: cardiovascular benefits, sources and sustainability. Nat Rev Cardiol. 2009;6:753–8. CrossRef
- Lee JH, O’Keefe Jr JH, Lavie CJ, et al. Omega-3 Fatty Acids for Cardioprotection. Mayo Clin Proc. 2008;83(3):324–32. CrossRef
- Lavie CJ. Fish Oil Therapy: gaining credibility. Future Cardiol. 2009;5(6):533–9. CrossRef
- Should We Start Prescribing Omega-3 Polyunsaturated Fatty Acids in Chronic Heart Failure?
Current Heart Failure Reports
Volume 9, Issue 1 , pp 8-13
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links
- Heart failure
- Fish oils
- Fatty acids
- Pharmacologic therapy
- α-Linolenic acid
- Eicosapentaenoic acid
- Docosahexaenoic acid
- Industry Sectors